Daniel Spratt, Chair and Professor of Radiation Oncology at Case Western Reserve University, shared a post on X by Tyler Seibert, Assistant Professor in the Division of Radiation Oncology and a member of the RMAS Center for Precision Radiation Medicine (CPRM), adding:
“Truly honored to speak PCF Science in front of countless giants in the field to discuss the ongoing legacy of Felix Feng and our practice-changing results showing for the 1st time in history a prospectively validated predictive biomarker for hormone therapy in prostate cancer!”
Quoting Tyler Seibert‘s post:
“Daniel Spratt giving the Felix Feng Legacy Lecture.
Felix’s impact on patients is mind-boggling. And will continue for decades, at minimum. Amazingly, his impact on team science and mentoring in Prostate Cancer may be even larger!”
More posts featuring Daniel Spratt on OncoDaily.
